AI assistant
Sending…
Anterix Inc. — Director's Dealing 2025
May 22, 2025
33018_dirs_2025-05-22_01997e07-73ba-4c30-b294-07d9989078cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2025-05-20
Reporting Person: Guttman-McCabe Christopher (Chief Reg & Comm Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-20 | Stock Option (Right to Buy) | $34.96 | A | 53491 | Acquired | 2035-05-20 | Common Stock (53491) | Direct |
Footnotes
F1: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19